Imurikagurisha rya Guangzhou API muri 2021

gae

86th Ubushinwa Mpuzamahanga Yimiti Yimiti / Abahuza / Gupakira / Imurikagurisha ryibikoresho (API Ubushinwa muri make)

Uwayiteguye: Urubingo Sinopharm Exhibition Co., Ltd.

Igihe cyo kumurika: 26-28 Gicurasi, 2021

Ikibanza: Ubushinwa butumiza no kohereza ibicuruzwa hanze (Guangzhou)

Igipimo cyimurikabikorwa: metero kare 60.000

Abamurika: 1500+

Umubare w'abumva: 60000+

Twebwe,Uruganda rwa Pharmaceutiaclifitwe na Shanghai Pharma.,azitabirawe Ubushinwa butumiza no kohereza ibicuruzwa mu mahanga (Guangzhou)kuri 10.2M15 kuri twe ku nshuro ya 86 Ubushinwa Mpuzamahanga yimiti yimiti / Umuhuza / Gupakira / Imurikagurisha ryibikoresho (API Ubushinwa muri make)

Mu myaka yashize, igihugu cyanjye cyagiye gikurikirana politiki zitandukanye zo gushishikariza no gushyigikira iterambere ry’inganda zikomoka ku binyabuzima. Ni muri urwo rwego, inganda zikomoka ku binyabuzima nazo zatangiye kwinjira mu cyiciro cy’iterambere ryihuse, kandi zigaragaza imbaraga zikomeye zo gukura. Kugeza ubu, umuvuduko w’isoko ryayo watangiye kurenga buhoro buhoro uko ibintu bimeze ku isoko ry’imiti. Raporo ya Frost & Sullivan ivuga ko mu 2019, isoko ry’ibinyabuzima ry’Ubushinwa ryageze kuri miliyari 317.2. Hamwe n'ubwiyongere buhendutse, ubwiyongere bw'abaturage barwayi ndetse no kwagura ubwishingizi bw'ubuvuzi, isoko ry’ibinyabuzima biteganijwe ko rizagera kuri miliyari 464.4 mu 2021.

Noneho, imbere y’isoko rinini ry’isoko, ni ubuhe buryo nyamukuru bwo gushora imari mu nganda zikomoka ku binyabuzima bikwiye kwitabwaho mu 2021? Nk’uko inganda zibitangaza, hashingiwe ku gusubira inyuma kw’urwego rwa farumasi, birasabwa kwita ku mirongo itatu y’ishoramari mu rwego rusange rwo kuzamura inganda.:

一.Ibigo byujuje ubuziranenge bushya bifite ubushobozi bwo guhangana ku isi

Ubuvuzi bwamye ari inganda izuba riva hamwe niterambere rikomeye. Icyakora, inyuma y’uko uruganda rukora imiti rwinjira mu iterambere ryiza kandi inganda zikaba zihutisha guhinduka, iterambere ry’imiti igezweho n’amasosiyete ikora imiti ni urufunguzo rwo gukemura ibibazo by’amavuriro bidakenewe, bikomeza kandi birushanwe. 

Kugeza ubu, ukurikije isi yose, ibigo bikomeye bikorerwamo ibya farumasi byose ni uruganda rukora imiti. Kurugero, agaciro k'isoko rya Johnson & Johnson, gafite imiti n'ibikoresho, kangana na miliyari 374.5 z'amadolari y'Abanyamerika, kandi agaciro k'isoko ry'amasosiyete akomeye y’imiti nka Roche na Pfizer nayo arenga miliyari 100 z'amadolari y'Amerika; ariko nka Teva Pharmaceuticals, imwe mu masosiyete akomeye ku isi y’ibiyobyabwenge, ifite isoko rya miliyari 12.3 z'amadolari gusa. Birashobora kugaragara uhereye hejuru ko guhanga udushya byabaye imbaraga zikomeye zo guteza imbere iterambere ry’inganda n’ibinyabuzima.

Birakwiye ko tumenya ko niba dushaka kugira amasoko menshi, ntibihagije kwishingikiriza kumasoko yimbere mu gihugu wenyine. Gusa mugusunika ibiyobyabwenge byapiganwa mumahanga mumahanga no kwitabira amarushanwa kumasoko yisi yose hamwe n'umwanya munini dushobora kugira amahirwe yo kubona inyungu nziza. . Kubera iyo mpamvu, inganda muri rusange zizera ko ibigo byujuje ubuziranenge bifite ubuhanga bwo guhangana ku isi bifite amahirwe menshi yo kwiteza imbere. Birasabwa kwita ku masosiyete akora imiti yubuhanga yashizeho uburyo bwo kugurisha mu mahanga.

二.Bijyanye na DRGs "urwego rw'abagenerwabikorwa

Mu 2021, ubwishyu nyabwo bwa DRGs buzatangira, buzagira ingaruka zikomeye ku gusuzuma no kuvura kwa muganga, amafaranga yo kugenzura ubwishingizi bw'ubuvuzi, n'ibindi. Urugero, iyo DRG imaze gushyirwa mu bikorwa, ibitaro bizagerageza kugabanya gukoresha imiti imwe ihenze cyane, ndetse no kumiti yumwimerere yubushakashatsi, ibigo bikorerwamo ibya farumasi bireba byangirika cyane nibidahinduka mugihe.

Ariko, nubwo ibiyobyabwenge nibigo bimwe bizagorwa cyane. Icyakora, inganda ziteganya ko ubwoko bwibiyobyabwenge bifite imiti ikomeye y’ibiyobyabwenge, imiti yihutirwa, ubuvuzi bwa nyuma n’imiti yo hanze ntibishobora kugira ingaruka, kandi mu gihe cyo gusuzuma inyungu-y’ibiciro, bizateza imbere ubwiyongere bw’igipimo cya ICL no gutumiza mu mahanga; gusimbuza inganda za IVD. Mubyongeyeho, ibikoresho byingenzi byo hejuru (ibikoresho fatizo nibikoresho, APIs zemewe) nabyo birashobora kubyungukiramo. Birasabwa kwitondera: WuXi Biologics, Tofflon, Kailai Ying nandi masosiyete.

三.Ibiyobyabwenge byateye imbere cyane R&D outsourcing field

Bitewe n’ibintu nko kwiyongera muri rusange gushora imari mu bya farumasi R&D ku isi ndetse na politiki nziza y’imbere mu gihugu, ni ubwumvikane mu nganda ko isoko rya serivisi y’ibiyobyabwenge R&D itanga isoko (ni ukuvuga CXO), igice cyingenzi cy’uruganda rw’ibiyobyabwenge rushya, biragaragara inyungu.

Abashinzwe inganda bemeza ko gutangiza ubu bigenda bihinduka imbaraga nyamukuru mu bushakashatsi no guteza imbere imiti igezweho mu nganda zikomoka ku binyabuzima. Ariko, kubera kubura impano, inkunga, n'umwanya, abatangiye ubusanzwe borohereza abakozi kandi bagakurikirana imikorere ihanitse kandi ihendutse. Kubwibyo, batunzwe nibigo bya CXO. Ukunda kuba hejuru. Byumvikane ko isosiyete ikora ku rutonde rwa CMO yavuze ko kubera izo mpamvu zavuzwe haruguru, umubare w’ibigo bitangiza bio-udushya twangiza ibiyobyabwenge mu mikorere y’amasosiyete ya CXO wagiye wiyongera buhoro buhoro mu myaka yashize, kandi na byo bikaba isoko y’intererano. kuzamuka kwiterambere rya sosiyete CXO ninyungu.


Igihe cyo kohereza: Gicurasi-13-2021